nafamostat has been researched along with thromboxane b2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawiec, M; Bodzenta-Lukaszyk, A; Gabryelewicz, A; Lukaszyk, A | 1 |
| Chenoweth, D; Fitzgibbon, C; Greene, E; Kreil, E; Montalescot, G; Robinson, D; Zapol, WM | 1 |
| Itokawa, Y; Morita, S; Nakai, I; Oka, T; Shimizu, Y; Uchiyama, K; Yoshimura, T | 1 |
3 other study(ies) available for nafamostat and thromboxane b2
| Article | Year |
|---|---|
Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
Topics: Acute Disease; Animals; Benzamidines; Blood Platelets; Dogs; Guanidines; Male; Pancreatitis; Platelet Aggregation Inhibitors; Platelet Count; Protease Inhibitors; Thromboxane B2 | 1992 |
Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions.
Topics: Animals; Benzamidines; Blood Pressure; Complement C3a; Complement Inactivator Proteins; Drug Interactions; Guanidines; Hemodynamics; Heparin; Hypertension, Pulmonary; Lung; Protamines; Protease Inhibitors; Pulmonary Artery; Sheep; Thromboxane B2; Vascular Resistance | 1989 |
Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation.
Topics: Animals; Benzamidines; Dogs; Guanidines; Male; Nitrites; Pancreas; Pancreas Transplantation; Protease Inhibitors; Reperfusion Injury; Thromboxane B2; Transplantation, Autologous | 1995 |